The authors specify that IL-11 produced by breast cancer cells induces osteoclast formation and bone resorption by two mechanisms, the first related to the production of RANKL by stromal cells/osteoblasts, and the second related to the rise of osteoclast progenitor through IL-11 derived from tumour cells. This evidence concerns the gene TNFSF11 and neoplasm.